Taking advantage of the lack of regulations on the third Covid-19 vaccination, regional heads receive booster shots. They claim their duties are as demanding as health workers.

There is no longer any need for the government to be responsible for research into the Nusantara vaccine being promoted by former Minister of Health Terawan Agus Putranto. None of the claims about it have been tested clinically.

Robert O. Dillman, Head of Aivita Biomedical, is suspected of violating a number of US research protocols. This is similar to Terawan Agus Putranto’s ‘brain washing’ method.

After failing to pass the Phase 1 clinical trial, researchers continue to work on the Nusantara vaccine pioneered by Terawan Agus Putranto, but under a new arrangement. The Indonesian Military is said to be divided in its stance on the polemic over the vaccine. In the United States, this research is also said to be problematic. Tempo investigation found that some of the claims made by Aivita, the company that developed the dendritic cell method, did not match reality.

Weekly News Summary.

The Food and Drug Monitoring Agency discovered various irregularities in Nusantara vaccine’s research. Clinical trials would have to start over.

The Nusantara vaccine is not suitable for Indonesia, which needs to inoculate large numbers of people. Existing vaccines are already proven effective for old people and those with other health conditions.

Terawan Agus Putranto is promoting the Nusantara vaccine to a number of officials. The National Institute of Health Research and Development does not fully supported research plans for this dendritic-cell vaccine. Terawan is also attaching researchers’ names without their consent.

Based on dendritic cells, the Nusantara vaccine is deemed too sophisticated for use against the Covid-19 virus. In its country of origin, the dendritic cell-based vaccine is used for personalized cancer treatment.